GSK plc GLAXF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.85B | 6.48B | 7.83B | 7.53B | 7.22B |
| Total Depreciation and Amortization | 1.09B | 934.69M | 1.46B | 1.87B | 2.96B |
| Total Amortization of Deferred Charges | 292.59M | 292.59M | 292.59M | 292.59M | 270.22M |
| Total Other Non-Cash Items | 4.13B | 4.29B | 3.73B | 3.06B | 3.41B |
| Change in Net Operating Assets | 597.81M | -825.42M | -2.95B | -2.49B | -3.64B |
| Cash from Operations | 11.96B | 11.17B | 10.36B | 10.27B | 10.22B |
| Capital Expenditure | -2.00B | -1.92B | -1.82B | -1.79B | -1.72B |
| Sale of Property, Plant, and Equipment | 61.73M | 64.44M | 67.09M | 31.97M | 92.80M |
| Cash Acquisitions | -12.62B | -4.03B | -3.12B | -2.23B | -2.26B |
| Divestitures | 334.07M | 352.90M | 295.36M | -35.98M | -43.72M |
| Other Investing Activities | -410.05M | -806.74M | -1.54B | -1.56B | -1.84B |
| Cash from Investing | -14.64B | -6.34B | -6.12B | -5.58B | -5.77B |
| Total Debt Issued | 8.34B | 1.95B | 2.32B | 3.19B | 3.98B |
| Total Debt Repaid | -2.05B | -1.17B | -1.79B | -1.93B | -3.00B |
| Issuance of Common Stock | 10.00M | 10.00M | 11.00M | 15.00M | 14.00M |
| Repurchase of Common Stock | -886.00M | -1.20B | -1.46B | -1.38B | -1.13B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.62B | -3.58B | -3.48B | -3.38B | -3.31B |
| Other Financing Activities | -782.00M | -964.00M | -764.00M | -1.02B | -1.01B |
| Cash from Financing | 2.62B | -5.43B | -5.71B | -5.00B | -4.94B |
| Foreign Exchange rate Adjustments | -106.96M | 18.33M | -7.01M | -23.56M | 39.93M |
| Miscellaneous Cash Flow Adjustments | 57.72M | 57.72M | -- | -- | -- |
| Net Change in Cash | -111.17M | -519.33M | -1.47B | -336.31M | -451.89M |